Dobbins Dachshunds

Parent health testing

• Vet Wellness Exam

  Show less

  A breeder may perform additional tests on their dogs that do not fall into these general categories. These tests may be more uncommon or very specific to a particular breed.

  Show less
• Progressive Retinal Atrophy (PRA), Generalized, Neuronal Ceroid Lipofuscinosis 1 (NCL1), Dachshund Type, Mucopolysaccharidosis IIIA (MPS IIIA), Dachshund Type, von Willebrand Disease II (vWD II), von Willebrand Disease I (vWD I), Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency, Stargardt Disease, Spongy Degeneration with Cerebellar Ataxia (SDCA2) mutation originally found in Belgian Shepherd Dog, Spongy Degeneration with Cerebellar Ataxia (SDCA1) mutation originally found in Belgian Shepherd Dog and Malinois, Spinocerebellar Ataxia with Myokymia (KCNJ10), Retinal Dysplasia/Oculoskeletal Dysplasia 2, Shar-Pei Autoinflammatory Disease, Severe Combined Immunodeficiency Disease, Terrier Type, Severe Combined Immunodeficiency Disease, Frisian Water Dog Type, Sensory Neuropathy, Border Collie Type (SN), Renal Cystadenocarcinoma and Nodular Dermatofibrosis (RCND), Recurrent Inflammatory Pulmonary (Collie Type) - Single Assay Test, Pyruvate Kinase Deficiency (PKD), Pug Type, Pyruvate Kinase Deficiency (PKD), Labrador Retriever Type, Pyruvate Kinase Deficiency (PKD), Cairn Terrier Type, Pyruvate Kinase Deficiency (PKD), Beagle Type, Pyruvate Kinase Deficiency, Basenji Type (PKD), Pyruvate Dehydrogenase Phosphatase 1 Deficiency (PDP1), Protein-Losing Nephropathy (PLN; NPHS1 Gene Variant), Early Onset Progressive Retinal Atrophy (EOPRA), Primary Open Angle Glaucoma (ADAMST17 Exon 11), Primary Lens Luxation (PLL), Primary Hyperoxaluria, Primary Ciliary Dyskenesia (Malamute Type) - Single Assay Test, Prekallikrein Deficiency, Fletcher Trait, Polycystic Kidney Disease (PKD), Pituitary Dwarfism, P2RY12 Receptor Platelet Disorder, Osteogenesis Imperfecta (OI), Dachshund Type, Osteochondrodysplasia, Miniature Poodle Type, Neuronal Ceroid Lipofuscinosis 8 (NCL8), Australian Shepherd Type, Neuronal Ceroid Lipofuscinosis 7 (NCL7), Neuronal Ceroid Lipofuscinosis 6 (NCL 6), Neuronal Ceroid Lipofuscinosis 5 (NCL5), Golden Retriever Type, Neuronal Ceroid Lipofuscinosis 5 (NCL5), Border Collie Type, Neuronal Ceroid Lipofuscinosis 10 (NCL10), American Bulldog Type, Neuroaxonal Dystrophy (NAD), Spanish Water Dog Type, Neuroaxonal Dystrophy NAD, Neonatal Encephalopathy with Seizures (NEwS), Neonatal Cortical Cerebellar Degeneration (NCCD), Nemaline Myopathy, American Bulldog Type, Narcolepsy, Dachshund Type, Myotonia Congenita, Schnauzer Type, Myotonia Congenita, Australian Cattle Dog Type, Musladin-Leuke Syndrome (MLS), Muscular Dystrophy, Ullrich-type; mutation originally found in Landseer, Mucopolysaccharidosis Type IIIB (MPS IIIB), Microphthalmia Syndrome (PES), Methemoglobinemia, May-Hegglin Anomaly, Malignant Hyperthermia (MH), Macular Corneal Dystrophy, MCD (CHST6), Lundehund Syndrome, Long QT Syndrome, Limb Girdle Muscular Dystrophy, Boston Terrier, Ligneous Membranitis, LM (PLG), Lethal Acrodermatitis (LAD), Bull Terrier Type, Late Onset Ataxia, Spinocerebellar Ataxia (LOA, SCA), Laryngeal Paralysis (Bull Terrier Type) - Single Assay Test, Lagotto Storage Disease (LSD), L-2-Hydroxyglutaric Aciduria (L2HGA), Staffordshire Bull Terrier Type, Juvenile Laryngeal Paralysis & Polyneuropathy (JLPP), Juvenile Myoclonic Epilepsy (JME), Inflammatory Myopathy (Myositis), Ichthyosis, American Bulldog Type, Hypomyelination, Weimaraner Type, Hypocatalasia, Hereditary Vitamin D-Resistant Rickets (HVDRR), Hereditary Nasal Parakeratosis (HNPK), Hereditary Ataxia, Cerebellar Ataxia, Gondysgenesis and Glaucoma, Border Collie Type, GM2 Gangliosidosis, Poodle Type, GM1 Gangliosidosis (GLB1), Shiba Inu Type, GM1 Gangliosidosis, Portuguese Water Dog Type, Glycogen Storage Disease Type VII, GSD VII, Glycogen Storage Disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM Wachtelhund Variant), Glycogen Storage Disease Type IIIA, GSD IIIA, Glycogen Storage Disease Type IA, GSD IA, Glanzmann's Thrombasthenia, Great Pyrenees Type, Fetal-Onset Neonatal Neuroaxonal Dystrophy (MFN1), Fanconi Syndrome, Familial Nephropathy, English Springer Spaniel Type, Familial Nephropathy, Cocker Spaniel Type, Factor IX Deficiency (G418E), Factor VII Deficiency, Exercise Induced Collapse (EIC), Episodic Falling Syndrome (EFS), Ehlers-Danlos Syndrome, Early Adult Onset Deafness (EAOD), Dystrophic Epidermolysis Bullosa, Dry Eye Curly Coat Syndrome (CKSID), Dilated Cardiomyopathy 2 (DCM2), Dilated Cardiomyopathy 1 (DCM1), Diffuse cystic renal dysplasia and hepatic fibrosis, Degenerative Myelopathy (DM; SOD1A), Deafness and Vestibular Dysfunction, Doberman Pinscher Type, Day Blindness, Achromatopsia, Cystinuria Type II-B, Miniature Pinscher Type, Cystinuria Type II-A, Australian Cattle Dog Type, Cystinuria Type 1A, Newfoundland Type, Craniomandibular Osteopathy (CMO), Congenital Stationary Night Blindness (CSNB), Congenital Myasthenic Syndrome (CMS), Old Danish Pointer Type, Congenital Myasthenic Syndrome (CMS), Labrador Retriever Type, Congenital Macrothrombocytopenia, Congenital Hypothyroidism with Goiter, Terrier Type (CHG), Compliment 3 Deficiency (C3), Collie Eye Anomaly (CEA), Cleft Palate (ADAMTS20), Chondrodysplasia/Dwarfism, Centronuclear Myopathy (CNM), Cardiomyopathy and Juvenile Mortality (YARS2), Canine Multiple System Degeneration (Chinese Crested Type), Canine Multifocal Retinopathy (cmr3; BEST1 Exon 10 SNP), Bernard-Soulier Syndrome, Cocker Spaniel Type, Bald Thigh Syndrome (IGFBP5), Alexander Disease, Acral Mutilation Syndrome (AMS), Alanine Aminotransferase Activity, Animal Genetics Panel, DNA Disease Panel

  Show less

  Genetic testing reduces the chance of passing down a wide variety of hereditary diseases of differing prevalence and severity such as Progressive Retinal Atrophy (an eye disease) and Von Willebrand's Disease (a blood disease).

  Show less